# Vertiv Holdings Co: financial statements, quarterly

VRT · NYSE · CIK 1674101 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrt.md) · [Financials](/companies/vrt/financials.md) · [Filings](/companies/vrt/filings.md) · [Insiders](/companies/vrt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vrt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,743](/filings/0001628280-24-043698.md) | [1,865 d](/filings/0001674101-26-000008.md) | [1,639](/filings/0001628280-25-019372.md) | [1,953](/filings/0001674101-25-000008.md) | [2,074](/filings/0001674101-25-000024.md) | [2,346 d](/filings/0001674101-26-000008.md) | [2,036](/filings/0001628280-26-026556.md) | [2,638](/filings/0001628280-26-050609.md) | [2,676](/filings/0001674101-25-000024.md) | [2,880 d](/filings/0001674101-26-000008.md) | [2,650](/filings/0001628280-26-026556.md) | [3,274](/filings/0001628280-26-050609.md) |
| Cost of revenue | $m | [1,115](/filings/0001628280-24-043698.md) | [1,182 d](/filings/0001674101-26-000008.md) | [1,073](/filings/0001628280-25-019372.md) | [1,212](/filings/0001674101-25-000008.md) | [1,317](/filings/0001674101-25-000024.md) | [1,476 d](/filings/0001674101-26-000008.md) | [1,350](/filings/0001628280-26-026556.md) | [1,742](/filings/0001628280-26-050609.md) | [1,665](/filings/0001674101-25-000024.md) | [1,759 d](/filings/0001674101-26-000008.md) | [1,650](/filings/0001628280-26-026556.md) | [2,039](/filings/0001628280-26-050609.md) |
| Selling, general and administrative | $m | [327](/filings/0001628280-24-043698.md) | [349 d](/filings/0001674101-26-000008.md) | [314](/filings/0001628280-25-019372.md) | [364](/filings/0001674101-25-000008.md) | [335](/filings/0001674101-25-000024.md) | [362 d](/filings/0001674101-26-000008.md) | [346](/filings/0001628280-26-026556.md) | [396](/filings/0001628280-26-050609.md) | [414](/filings/0001674101-25-000024.md) | [462 d](/filings/0001674101-26-000008.md) | [457](/filings/0001628280-26-026556.md) | [494](/filings/0001628280-26-050609.md) |
| Operating income | $m | [251](/filings/0001628280-24-043698.md) | [285 d](/filings/0001674101-26-000008.md) | [203](/filings/0001628280-25-019372.md) | [336](/filings/0001674101-25-000008.md) | [372](/filings/0001674101-25-000024.md) | [457 d](/filings/0001674101-26-000008.md) | [291](/filings/0001628280-26-026556.md) | [442](/filings/0001628280-26-050609.md) | [517](/filings/0001674101-25-000024.md) | [580 d](/filings/0001674101-26-000008.md) | [440](/filings/0001628280-26-026556.md) | [638](/filings/0001628280-26-050609.md) |
| Interest expense | $m | [43.5](/filings/0001628280-24-043698.md) | [42.9 d](/filings/0001674101-26-000008.md) | [39.0](/filings/0001628280-25-019372.md) | [44.8](/filings/0001674101-25-000008.md) | [35.9](/filings/0001674101-25-000024.md) | [30.7 d](/filings/0001674101-26-000008.md) | [25.3](/filings/0001628280-26-026556.md) | [21.3](/filings/0001628280-26-050609.md) | [22.8](/filings/0001674101-25-000024.md) | [16.7 d](/filings/0001674101-26-000008.md) | [(4.4)](/filings/0001628280-26-026556.md) | [17.4](/filings/0001628280-26-050609.md) |
| Income tax | $m | [51.7](/filings/0001628280-24-043698.md) | [(45.3) d](/filings/0001674101-26-000008.md) | [(7.1)](/filings/0001628280-25-019372.md) | [86.6](/filings/0001674101-25-000008.md) | [91.9](/filings/0001674101-25-000024.md) | [98.2 d](/filings/0001674101-26-000008.md) | [101](/filings/0001628280-26-026556.md) | [96.9](/filings/0001628280-26-050609.md) | [93.7](/filings/0001674101-25-000024.md) | [118 d](/filings/0001674101-26-000008.md) | [48.2](/filings/0001628280-26-026556.md) | [122](/filings/0001628280-26-050609.md) |
| Net income | $m | [94.1](/filings/0001628280-24-043698.md) | [233 d](/filings/0001674101-26-000008.md) | [(5.9)](/filings/0001674101-25-000024.md) | [178](/filings/0001674101-25-000024.md) | [177](/filings/0001674101-25-000024.md) | [147 d](/filings/0001674101-26-000008.md) | [165](/filings/0001628280-26-050609.md) | [324](/filings/0001628280-26-050609.md) | [399](/filings/0001674101-25-000024.md) | [446 d](/filings/0001674101-26-000008.md) | [390](/filings/0001628280-26-050609.md) | [498](/filings/0001628280-26-050609.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001628280-24-043698.md) | not reported | [(0.02)](/filings/0001628280-25-019372.md) | [0.46](/filings/0001674101-25-000008.md) | [0.46](/filings/0001674101-25-000024.md) | not reported | [0.42](/filings/0001628280-26-026556.md) | [0.83](/filings/0001628280-26-050609.md) | [1.02](/filings/0001674101-25-000024.md) | not reported | [0.99](/filings/0001628280-26-026556.md) | [1.27](/filings/0001628280-26-050609.md) |
| Basic EPS | $ per share | [0.25](/filings/0001628280-24-043698.md) | not reported | [(0.02)](/filings/0001628280-25-019372.md) | [0.48](/filings/0001674101-25-000008.md) | [0.47](/filings/0001674101-25-000024.md) | not reported | [0.43](/filings/0001628280-26-026556.md) | [0.85](/filings/0001628280-26-050609.md) | [1.04](/filings/0001674101-25-000024.md) | not reported | [1.02](/filings/0001628280-26-026556.md) | [1.29](/filings/0001628280-26-050609.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001628280-23-035351.md) | [0.8](/filings/0001674101-26-000008.md) | [0.3](/filings/0001628280-24-018417.md) | [0.6](/filings/0001628280-24-033173.md) | [0.9](/filings/0001628280-24-043698.md) | [1.2](/filings/0001674101-26-000008.md) | [1.5](/filings/0001628280-25-019372.md) | [1.6](/filings/0001674101-25-000008.md) | [1.4](/filings/0001674101-25-000024.md) | [1.7](/filings/0001628280-26-050609.md) | [2.2](/filings/0001628280-26-026556.md) | [2.8](/filings/0001628280-26-050609.md) |
| Current assets | $bn | [3.6](/filings/0001628280-23-035351.md) | [4.0](/filings/0001628280-25-005905.md) | [3.6](/filings/0001628280-24-018417.md) | [4.2](/filings/0001628280-24-033173.md) | [4.8](/filings/0001628280-24-043698.md) | [5.1](/filings/0001674101-26-000008.md) | [5.5](/filings/0001628280-25-019372.md) | [6.3](/filings/0001674101-25-000008.md) | [6.5](/filings/0001674101-25-000024.md) | [6.8](/filings/0001628280-26-050609.md) | [8.0](/filings/0001628280-26-026556.md) | [10.0](/filings/0001628280-26-050609.md) |
| Total assets | $bn | [7.4](/filings/0001628280-23-035351.md) | [8.0](/filings/0001628280-25-005905.md) | [7.6](/filings/0001628280-24-018417.md) | [8.1](/filings/0001628280-24-033173.md) | [8.9](/filings/0001628280-24-043698.md) | [9.1](/filings/0001674101-26-000008.md) | [9.5](/filings/0001628280-25-019372.md) | [10.4](/filings/0001674101-25-000008.md) | [10.8](/filings/0001674101-25-000024.md) | [12.2](/filings/0001628280-26-050609.md) | [13.4](/filings/0001628280-26-026556.md) | [15.9](/filings/0001628280-26-050609.md) |
| Current liabilities | $bn | [2.1](/filings/0001628280-23-035351.md) | [2.3](/filings/0001628280-25-005905.md) | [2.7](/filings/0001628280-24-018417.md) | [3.1](/filings/0001628280-24-033173.md) | [3.5](/filings/0001628280-24-043698.md) | [3.1](/filings/0001674101-26-000008.md) | [3.2](/filings/0001628280-25-019372.md) | [3.6](/filings/0001674101-25-000008.md) | [3.6](/filings/0001674101-25-000024.md) | [4.4](/filings/0001628280-26-050609.md) | [5.3](/filings/0001628280-26-026556.md) | [7.2](/filings/0001628280-26-050609.md) |
| Total liabilities | $bn | [5.7](/filings/0001628280-23-035351.md) | [6.0](/filings/0001628280-25-005905.md) | [6.2](/filings/0001628280-24-018417.md) | [6.6](/filings/0001628280-24-033173.md) | [7.1](/filings/0001628280-24-043698.md) | [6.7](/filings/0001674101-26-000008.md) | [6.8](/filings/0001628280-25-019372.md) | [7.3](/filings/0001674101-25-000008.md) | [7.3](/filings/0001674101-25-000024.md) | [8.3](/filings/0001628280-26-050609.md) | [9.2](/filings/0001628280-26-026556.md) | [11.1](/filings/0001628280-26-050609.md) |
| Long-term debt | $bn | [2.9](/filings/0001628280-23-035351.md) | [2.9](/filings/0001628280-25-005905.md) | [2.9](/filings/0001628280-24-018417.md) | [2.9](/filings/0001628280-24-033173.md) | [2.9](/filings/0001628280-24-043698.md) | [2.9](/filings/0001674101-26-000008.md) | [2.9](/filings/0001628280-25-019372.md) | [2.9](/filings/0001674101-25-000008.md) | [2.9](/filings/0001674101-25-000024.md) | [2.9](/filings/0001628280-26-050609.md) | [2.9](/filings/0001628280-26-026556.md) | [2.9](/filings/0001628280-26-050609.md) |
| Current portion of debt | $bn | [0.0](/filings/0001628280-23-035351.md) | [0.0](/filings/0001628280-25-005905.md) | [0.0](/filings/0001628280-24-018417.md) | [0.0](/filings/0001628280-24-033173.md) | [0.0](/filings/0001628280-24-043698.md) | [0.0](/filings/0001674101-26-000008.md) | [0.0](/filings/0001628280-25-019372.md) | [0.0](/filings/0001674101-25-000008.md) | [0.0](/filings/0001674101-25-000024.md) | [0.0](/filings/0001628280-26-050609.md) | [0.0](/filings/0001628280-26-026556.md) | [0.0](/filings/0001628280-26-050609.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.7](/filings/0001628280-24-043698.md) | [2.0](/filings/0001674101-26-000008.md) | [1.4](/filings/0001674101-25-000024.md) | [1.5](/filings/0001674101-25-000024.md) | [1.8](/filings/0001674101-25-000024.md) | [2.4](/filings/0001628280-26-050609.md) | [2.7](/filings/0001628280-26-050609.md) | [3.1](/filings/0001628280-26-050609.md) | [3.5](/filings/0001674101-25-000024.md) | [3.9](/filings/0001628280-26-050609.md) | [4.2](/filings/0001628280-26-050609.md) | [4.8](/filings/0001628280-26-050609.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [249 d](/filings/0001628280-24-043698.md) | [356 d](/filings/0001674101-26-000008.md) | [138](/filings/0001628280-25-019372.md) | [382 d](/filings/0001674101-25-000008.md) | [375 d](/filings/0001674101-25-000024.md) | [425 d](/filings/0001674101-26-000008.md) | [303](/filings/0001628280-26-026556.md) | [323 d](/filings/0001628280-26-050609.md) | [509 d](/filings/0001674101-25-000024.md) | [979 d](/filings/0001674101-26-000008.md) | [767](/filings/0001628280-26-026556.md) | [1,100 d](/filings/0001628280-26-050609.md) |
| Capital expenditure | $m | [26.5 d](/filings/0001628280-24-043698.md) | [47.8 d](/filings/0001674101-26-000008.md) | [35.8](/filings/0001628280-25-019372.md) | [34.1](/filings/0001674101-25-000008.md) | [36.4](/filings/0001674101-25-000024.md) | [60.7 d](/filings/0001674101-26-000008.md) | [36.5](/filings/0001628280-26-026556.md) | [45.0](/filings/0001674101-25-000008.md) | [45.2](/filings/0001674101-25-000024.md) | [93.3 d](/filings/0001674101-26-000008.md) | [113](/filings/0001628280-26-026556.md) | [173 d](/filings/0001628280-26-050609.md) |
| Dividends paid | $m | [0.0 d](/filings/0001628280-24-043698.md) | [9.5 d](/filings/0001674101-26-000008.md) | [9.3](/filings/0001628280-25-019372.md) | [9.4 d](/filings/0001674101-25-000008.md) | [9.4 d](/filings/0001674101-25-000024.md) | [14.1 d](/filings/0001674101-26-000008.md) | [14.2](/filings/0001628280-26-026556.md) | [14.2 d](/filings/0001628280-26-050609.md) | [14.2 d](/filings/0001674101-25-000024.md) | [24.0 d](/filings/0001674101-26-000008.md) | [23.9](/filings/0001628280-26-026556.md) | [23.9 d](/filings/0001628280-26-050609.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-043698.md) | [0.0 d](/filings/0001674101-26-000008.md) | [600](/filings/0001628280-25-019372.md) | [0.0 d](/filings/0001674101-25-000008.md) | [0.0 d](/filings/0001674101-25-000024.md) | [0.0 d](/filings/0001674101-26-000008.md) | [0.0](/filings/0001628280-25-019372.md) | [0.0 d](/filings/0001674101-25-000008.md) | [0.0 d](/filings/0001674101-25-000024.md) | [0.0 d](/filings/0001674101-26-000008.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [377](/filings/0001628280-23-035351.md) | [382](/filings/0001628280-24-018417.md) | [382](/filings/0001628280-24-033173.md) | [388](/filings/0001628280-24-043698.md) | [379](/filings/0001628280-25-019372.md) | [384](/filings/0001674101-25-000008.md) | [384](/filings/0001674101-25-000024.md) | [390](/filings/0001628280-26-026556.md) | [390](/filings/0001628280-26-050609.md) | [391](/filings/0001674101-25-000024.md) | [392](/filings/0001628280-26-026556.md) | [393](/filings/0001628280-26-050609.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 384,988,173 at 2026-07-27, from the cover of the [10-Q filed 2026-07-29](/filings/0001628280-26-050609.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.